|
1
|
Frazier Life Sciences Management
Palo Alto,
California
|
$183M
|
–
|
–
|
–
|
|
|
2
|
Medicxi Ventures Management
St. Helier,
Jersey
|
$135M
|
–
|
–
|
–
|
|
|
3
|
Jennison Associates
New York
|
$106M
|
+$43.5M
|
+3,108,810
|
+113%
|
|
|
4
|
|
$74.1M
|
+$13.3M
|
+953,310
|
+30%
|
|
|
5
|
Carlyle Group
Washington,
District of Columbia
|
$63.2M
|
–
|
–
|
–
|
|
|
6
|
|
$56.5M
|
+$2.74M
|
+196,197
|
+7%
|
|
|
7
|
Vanguard Group
Malvern,
Pennsylvania
|
$48.7M
|
+$6.77M
|
+484,568
|
+22%
|
|
|
8
|
Ensign Peak Advisors
Salt Lake City,
Utah
|
$46.7M
|
+$4.7M
|
+336,560
|
+15%
|
|
|
9
|
Woodline Partners
San Francisco,
California
|
$46.5M
|
+$25M
|
+1,787,422
|
+227%
|
|
|
10
|
NEA Management Company
Timonium,
Maryland
|
$35.4M
|
–
|
–
|
–
|
|
|
11
|
Avidity Partners Management
Dallas,
Texas
|
$32.6M
|
+$2.58M
|
+184,493
|
+11%
|
|
|
12
|
Portolan Capital Management
Boston,
Massachusetts
|
$30.7M
|
+$7.96M
|
+569,829
|
+50%
|
|
|
13
|
Gilder Gagnon Howe & Co
New York
|
$29.3M
|
+$2.11M
|
+150,624
|
+10%
|
|
|
14
|
Checkpoint Capital
San Francisco,
California
|
$27.2M
|
+$8.8M
|
+629,307
|
+72%
|
|
|
15
|
|
$26.2M
|
+$20.3M
|
+1,449,073
|
New
|
|
|
16
|
Federated Hermes
Pittsburgh,
Pennsylvania
|
$25.4M
|
+$19.6M
|
+1,403,638
|
New
|
|
|
17
|
Fidelity Investments
Boston,
Massachusetts
|
$23.6M
|
+$18.2M
|
+1,301,458
|
+49,001%
|
|
|
18
|
Decheng Capital
Menlo Park,
California
|
$22.6M
|
+$5.59M
|
+400,000
|
+47%
|
|
|
19
|
GW&K Investment Management
Boston,
Massachusetts
|
$20.4M
|
+$7.35M
|
+525,640
|
+88%
|
|
|
20
|
Catalys Pacific
Tokyo,
Japan
|
$20.3M
|
+$5.6M
|
+400,610
|
+55%
|
|
|
21
|
683 Capital Management
New York
|
$18.3M
|
-$5.45M
|
-390,000
|
-28%
|
|
|
22
|
State Street
Boston,
Massachusetts
|
$16.7M
|
+$1.92M
|
+137,539
|
+18%
|
|
|
23
|
Saturn V Capital Management
Austin,
Texas
|
$15.8M
|
+$3.93M
|
+281,284
|
+47%
|
|
|
24
|
Propel Bio Management
Los Angeles,
California
|
$15.7M
|
–
|
–
|
–
|
|
|
25
|
Geode Capital Management
Boston,
Massachusetts
|
$15.6M
|
+$795K
|
+56,871
|
+7%
|
|
